nivolumab,cobolimab
bms,gsk
['nivo', 'nivolumab', 'cobolimab']
dr. gerald falchook of presenting the results of the amber study involving the #tim3 inhibitor (#cobolimab) in combination with #nivolumab! eager to see these data ! #asco22 
#MedicalOncologist tweeting on #immunotherapy, #drugdevelopment, #COVID19 & #HealthEcon. #NCI #CancerMoonshot Adult Immunotherapy Co-Chair. Tweets are mine.